Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer.
Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to compare FISH and IHC analysis of HER-2/neu from core needle and excisional biopsies of breast carcinoma specimens. Specimens were collected from 125 patients, 5 of which had received neoadjuvant chemotheraphy.
Summary of Findings
In 87% of specimens, there was complete concordance between FISH and IHC results and excisional and core needle biopsy specimens. Concordance was found between FISH and IHC results within a specimen 95% of the time, with most of the discordant specimens showing no IHC staining despite amplification by FISH. Core needle and excisional biopsies were concordant 92% of the time with FISH analysis and 98% of the time with IHC analysis. In 5 cases in which neoadjuvant chemotherapy was received, no differences between FISH or IHC were observed nor were there differences between core needle and excisional biopsy. The authors conclude that IHC is slightly more consistent than FISH, and that it is reasonable to examine both the core and excisional biopsy specimens especially in cases where the tumor characteristics are found to be different in the core needle and excisional biopsy.
Biospecimens
TissueBreastPreservation Types
Other PreservativeDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryMorphologyH-and-E microscopyDNAFISHPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of tissue acquisition Core needle biopsyExcisional biopsyFISH Specific Targeted nucleic acid HER-2/neuFISH Specific Technology platform FISHImmunohistochemistryImmunohistochemistry Specific Targeted peptide/protein HER-2/neu